GUFICBIO — Gufic Biosciences Share News
0.000.00%
Last trade - 00:00- IN₹39.29bn
- IN₹42.58bn
- IN₹9.44bn
Brief: Gufic Biosciences Received Approval From National Medical Products Administration, China For Product Prilocaine (API)
Brief: Gufic Biosciences - Cleared Brazilian Health Regulatory Audit For Gujarat Plant
Brief: India's Gufic Biosciences March-Qtr Net Profit From Cont Ops Falls
India's Gufic Biosciences rises after incorporating subsidiary in Ireland
Brief: India's Gufic Biosciences Ltd Dec-Quarter Net Profit From Continuing Operations Falls
Brief: India's Gufic Biosciences Sept-Quarter Profit Falls
Launched New Drug Delivery System Dual Chamber Bags At Affordable Price In India
Brief: Gufic Biosciences Says Promoter Intends To Sell Around 0.48% Stake In Co
Brief: Gufic Biosciences Says Got Permission From CDSCO To Make, Sell Isavuconazonium Sulfate API
Gufic Receives Dcgi Nod For Thymosin Alpha - 1
Brief: Gufic Biosciences Dec-Quarter Total Profit Rises
Brief: Gufic Biosciences Approves Increase In Capex To Tune Of 2 Bln Rupees
India's Gufic BioSciences rises as COVID-19 treatments boost results
Brief: Gufic Biosciences Posts June-Quarter Profit
Brief: Gufic Biosciences Gets Approval To Make & Market Liposomal Amphotericin B Injection
Brief: Gufic Biosciences Dec-Qtr Net Profit From Cont Ops Rises
Brief: India's Gufic Biosciences Sept Quarter Total Profit Rises
Brief: Gufic Lifesciences Pvt Ltd Can Now Expand Its Business In Territory Of Brazil
Brief: Gufic Biosciences Recommends Dividend Of 0.05 Rupees Per Share